Faster, more accurate tests for drug-resistant infections are hailed as a promising tool in the fight against antibiotic resistance, so much so that the US and Britain are offering millions in prize money for their development. A modeling study shows that better tests could, in theory, change the game and put drug-resistant bacteria at a reproductive disadvantage relative to more easily-treated strains — but with a caveat.
